Wolverine Trading, LLC Surface Oncology, Inc. Call Options Transaction History

Wolverine Trading, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	SELL	$0.62 - $1.21 $6,820 - $13,310	-11,000 Reduced 35.48%	20,000 $16,000
Q3 2022 Nov 14, 2022	BUY	$1.05 - $2.1 $4,725 - $9,450	4,500 Added 16.98%	31,000 $33,000
Q2 2022 Aug 15, 2022	BUY	$1.42 - $3.15 $6,390 - $14,175	4,500 Added 20.45%	26,500 $44,000
Q1 2022 May 16, 2022	SELL	$2.65 - $5.08 $17,755 - $34,036	-6,700 Reduced 23.34%	22,000 $62,000
Q3 2021 Nov 12, 2021	BUY	$5.16 - $7.98 $77,916 - $120,498	15,100 Added 111.03%	28,700 $215,000
Q2 2021 Aug 06, 2021	BUY	$6.45 - $9.09 $87,720 - $123,624	13,600 New	13,600 $101,000

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.